(1400 House floor votes analyzed - so far...)
Last Action: Read by title, under the rules, referred to the Committee on Health and Welfare.
Date: 2025-04-14
Author: Kathy Edmonston (R)
Pending: 🏛 Health and Welfare 47 📅 Not Scheduled



Last Action: Read by title, under the rules, referred to the Committee on House and Governmental Affairs.
Date: 2025-04-14
Author: Kathy Edmonston (R)
Pending: 🏛 House and Governmental Affairs 50 📅 Not Scheduled


Last Action: Effective date: 08/01/2025.
Date: 2025-06-11
Author: Kathy Edmonston (R)
📅 Not Scheduled
REMOVES: the requirement that the regulations be promulgated by Jan. 1, 2026.
Last Action: Effective date: 08/01/2025.
Date: 2025-06-11
Author: Kathy Edmonston (R)
📅 Not Scheduled
EXTENDS existing legislative carve out.
Last Action: Effective date: 08/01/2025.
Date: 2025-06-11
Author: Kathy Edmonston (R)
📅 Not Scheduled
WHY IS THIS CHANGE NECESSARY?
Provides that no healthcare professional licensing board or commission shall prohibit or restrict the prescribing, administering, or dispensing for an off-label use of a human drug that has been approved for a specific use by the U.S. Food and Drug Administration (FDA).